Patients with advanced lung cancer receiving pembrolizumab have worse survival when exposed to certain antibiotics, high-dose steroids, or proton pump inhibitors.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/do-co-medications-cut-immunotherapy-benefit-lung-cancer-2025a1000o6r?src=rss
Author :
Publish date : 2025-09-12 10:45:00
Copyright for syndicated content belongs to the linked Source.
